Any stock, in context
SYNCOMF · Healthcare
Syncom Formulations (India) Limited
Observation · 15 Oct 2026
How these are readSyncom Formulations (India) closed at ₹21.56 on 15 Oct 2026, 45.5% above its 200-day average and 13.0% above its 50-day average: above both lines. It sits 17.6% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 60.8%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +45.5%
- the long line
- vs 50-day
- +13.0%
- the short line
- From 52w high
- −17.6%
- ₹10.21₹27.49
- 3 months
- +60.9%
- sector median −2.7% · 5 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹15 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −3.96%
- 1W
- –
- 1M
- +16.93%
- 3M
- +60.85%
- YTD
- –
- 1Y
- +32.84%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.